Maravai LifeSciences Holdings, Inc.
NASDAQMaravai LifeSciences reports Q1 2026 results today carrying momentum that few in the life sciences tools sector can match right now — a 34% gain over the past month into a print that will test whether the fundamentals are catching up with the stock. The most striking signal heading into the release is from management itself. CEO Bernd Brust spent over $1.5 million buying MRVI…
Snapshot as of 23 Jun 2026
Maravai LifeSciences reports Q1 2026 results today carrying momentum that few in the life sciences tools sector can match right now — a 34% gain over the past month into a print that will test whether the fundamentals…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for MRVI — free to start on ORTEX.
Sign up for free →Open MRVI on ORTEX